Podcast
As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.
This month, we spoke with Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, director of pharmacy cancer care services at Mayo Clinic, to learn about the latest updates and pipeline treatments in prostate cancer. As treatments improve and prostate cancer potentially becomes more of a chronic illness, Soefje said pharmacists have a chance to shine.
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia